Taking On The Big Guns: Life As A Boutique Biosimilar Developer

MAbxience, a biosimilar R&D company founded in 2009 as the biotechnology arm of CHEMO group, has opened a new manufacturing plant in Leon, Spain at which it hopes to produce up to six new monoclonal antibody biosimilars for its target markets of Europe and Latin America.